ELI LILLY & Co (LLY)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $7.6M
- Aug 17 · Routine
- Form 4 sales
- 769
- On record
- Form 144 notices
- 22
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planDec 29 2025
Sold 3,593 shares at $1,085.04 ($3.9M)
Lilly Endowment INC, 10% owner
No 10b5-1 planSold 0% of holdings ($100B position)92.2M shares left0.1x usual sizeFiling
- 2 Form 4 saleNo planJan 5 +7 days
Sold 1,390 shares at $1,085.01 ($1.5M)
Lilly Endowment INC, 10% owner
No 10b5-1 planSold 0% of holdings ($100B position)92.2M shares left0x usual sizeFiling
- 3 Form 4 saleUnusualJan 7 +2 days
Sold 292,148 shares at $1,103.48 ($322M)
Lilly Endowment INC, 10% owner
No 10b5-1 planSold 0.3% of holdings ($102B position)91.9M shares left4.8x usual sizeFiling
- 4 Form 4 saleNo planMay 6 +119 days
Sold 15,828 shares at $995.36 ($15.8M)
Lilly Endowment INC, Other
No 10b5-1 planSold 0% of holdings ($91.5B position)91.9M shares left0.2x usual sizeFiling
- 5 Form 4 saleRoutineJun 10 +35 days
Sold 2,500 shares at $1,150.77 ($2.9M)
Yuffa Ilya, EVP&Pres, LLY USA&Global Capab
10b5-1 planSold 7.7% of holdings ($37.2M position)29,804 shares leftFiling
- 6 Form 4 saleRoutineAug 7 +58 days
Sold 5,000 shares at $1,190.00 ($6M)
Hakim Anat, EVP, GC & Secretary
10b5-1 planSold 29.6% of holdings ($20.1M position)11,875 shares leftFirst sale on recordFiling
- 7 Form 4 saleRoutineAug 10 +3 days
Sold 2,000 shares at $1,185.01 ($2.4M)
Zakrowski Donald A, SVP, Finance, & CAO
10b5-1 planSold 56.7% of holdings ($4.2M position)1,526 shares left2x usual sizeFiling
- 8 Form 4 saleRoutineAug 17 +7 days
Sold 6,500 shares at $1,175.10 ($7.6M)
Jonsson Patrik, EVP & President, LLY Int'l
10b5-1 planSold 10.7% of holdings ($71.3M position)54,147 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales, notices and lockups (newest 400 of 791)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | Form 4 sale | 6,500 | $7.6M | 10.7% | Routine | SEC |
| Aug 10, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 2,000 | $2.4M | 56.7% | Routine | SEC |
| Aug 7, 2026 | Hakim Anat | EVP, GC & Secretary | Form 4 sale | 5,000 | $6M | 29.6% | Routine | SEC |
| Jun 10, 2026 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Form 4 sale | 2,500 | $2.9M | 7.7% | Routine | SEC |
| May 6, 2026 | Lilly Endowment INC | Other | Form 4 sale | 15,828 | $15.8M | 0.0% | No plan | SEC |
| Jan 7, 2026 | Lilly Endowment INC | 10% owner | Form 4 sale | 292,148 | $322M | 0.3% | Unusual | SEC |
| Jan 5, 2026 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,390 | $1.5M | 0.0% | No plan | SEC |
| Dec 29, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,593 | $3.9M | 0.0% | No plan | SEC |
| Dec 24, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 2,629 | $2.9M | 0.0% | No plan | SEC |
| Dec 23, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 240 | $260k | 0.0% | No plan | SEC |
| Nov 25, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 15,632 | $17.3M | 0.0% | No plan | SEC |
| Nov 25, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 147,061 | $161M | 0.2% | No plan | SEC |
| Nov 24, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 142,307 | $152M | 0.2% | No plan | SEC |
| Nov 21, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 105,326 | $112M | 0.1% | No plan | SEC |
| Nov 20, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 37,148 | $39.1M | 0.0% | No plan | SEC |
| Nov 19, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 167,526 | $176M | 0.2% | No plan | SEC |
| Nov 18, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 60,213 | $62.3M | 0.1% | No plan | SEC |
| Nov 17, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 9,886 | $10.2M | 0.0% | No plan | SEC |
| Nov 14, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 178,295 | $75.9B | 0.2% | No plan | SEC |
| Nov 13, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 46,606 | $48M | 0.1% | No plan | SEC |
| Nov 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 1,000 | $1M | 26.0% | Routine | SEC |
| Nov 12, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 305,000 | $308M | 0.3% | Unusual | SEC |
| Nov 11, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 283,131 | $279M | 0.3% | Unusual | SEC |
| Nov 10, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 16,869 | $16.4M | 0.0% | No plan | SEC |
| Nov 5, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 40,432 | $38.5M | 0.0% | No plan | SEC |
| Nov 5, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 179,042 | $167M | 0.2% | No plan | SEC |
| Nov 4, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 526 | $479k | 0.0% | No plan | SEC |
| Nov 3, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 300,000 | $267M | 0.3% | Unusual | SEC |
| Oct 31, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 301,342 | $260M | 0.3% | Unusual | SEC |
| Oct 10, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,658 | $3.2M | 0.0% | No plan | SEC |
| Oct 9, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 10,602 | $9M | 0.0% | No plan | SEC |
| Oct 8, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 101,420 | $86.2M | 0.1% | No plan | SEC |
| Oct 7, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 26,795 | $22.7M | 0.0% | No plan | SEC |
| Oct 6, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 161,183 | $137M | 0.2% | No plan | SEC |
| Oct 3, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 192,404 | $161M | 0.2% | No plan | SEC |
| Oct 2, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 112,596 | $92.5M | 0.1% | No plan | SEC |
| Oct 1, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 215,822 | $177M | 0.2% | Unusual | SEC |
| Oct 1, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 135,193 | $107M | 0.1% | No plan | SEC |
| Sep 30, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 113,694 | $86.8M | 0.1% | No plan | SEC |
| Sep 19, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 23,665 | $18.1M | 0.0% | No plan | SEC |
| Sep 18, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 106,626 | $81.5M | 0.1% | No plan | SEC |
| Aug 28, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 1,000 | $735k | 20.7% | Routine | SEC |
| Aug 11, 2025 | Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | Form 4 sale | 1,250 | $784k | 4.5% | Routine | SEC |
| Jul 24, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 280,000 | $225M | 0.3% | Unusual | SEC |
| May 27, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 1,000 | $716k | 17.1% | Routine | SEC |
| May 14, 2025 | Yuffa Ilya | EVP & President, LLY Int'l | Form 4 sale | 1,250 | $937k | 4.3% | Routine | SEC |
| Mar 13, 2025 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 1,000 | $818k | 14.6% | Routine | SEC |
| Mar 3, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $204M | 0.2% | Unusual | SEC |
| Feb 25, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 225,000 | $203M | 0.2% | Unusual | SEC |
| Feb 24, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 60,432 | $1.6B | 0.1% | No plan | SEC |
| Feb 21, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 99,452 | $87.8M | 0.1% | No plan | SEC |
| Feb 20, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 14,685 | $12.9M | 0.0% | No plan | SEC |
| Feb 19, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 9,985 | $8.8M | 0.0% | No plan | SEC |
| Feb 13, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 35,446 | $31.2M | 0.0% | No plan | SEC |
| Feb 10, 2025 | Skovronsky Daniel | EVP, CSO & Pres. LRL & LLY Imm | Form 4 sale | 5,000 | $4.3M | 4.1% | No plan | SEC |
| Feb 6, 2025 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $184M | 0.2% | Unusual | SEC |
| Nov 8, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 900 | $723k | 14.1% | Routine | SEC |
| Sep 3, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 24,084 | $23.3M | 0.0% | No plan | SEC |
| Aug 27, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 24,552 | $23.8M | 0.0% | No plan | SEC |
| Aug 26, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 750 | $713k | 10.5% | Routine | SEC |
| Aug 22, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,196 | $3.1M | 0.0% | No plan | SEC |
| Jul 10, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $197M | 0.2% | Unusual | SEC |
| Jul 8, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 93,593 | $86M | 0.1% | No plan | SEC |
| Jul 5, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 52,369 | $47.9M | 0.1% | No plan | SEC |
| Jul 3, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 8,848 | $8.1M | 0.0% | No plan | SEC |
| Jul 1, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 58,749 | $53.8M | 0.1% | No plan | SEC |
| Jun 28, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,441 | $1.3M | 0.0% | No plan | SEC |
| Jun 25, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 188,100 | $170M | 0.2% | Unusual | SEC |
| Jun 24, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 17,229 | $15.5M | 0.0% | No plan | SEC |
| Jun 20, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 9,671 | $8.7M | 0.0% | No plan | SEC |
| Jun 17, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 194,978 | $173M | 0.2% | Unusual | SEC |
| Jun 14, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 15,022 | $13.3M | 0.0% | No plan | SEC |
| Jun 10, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 75,510 | $65M | 0.1% | No plan | SEC |
| Jun 7, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 139,490 | $119M | 0.1% | No plan | SEC |
| Jun 6, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 179,617 | $150M | 0.2% | Unusual | SEC |
| Jun 5, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 20,383 | $17M | 0.0% | No plan | SEC |
| Jun 3, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 192,794 | $160M | 0.2% | Unusual | SEC |
| Jun 3, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 750 | $615k | 9.5% | Routine | SEC |
| Jun 3, 2024 | Norton Johna | EVP, Global Quality | Form 4 sale | 7,056 | $5.8M | 21.7% | Routine | SEC |
| May 31, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 22,206 | $18.3M | 0.0% | No plan | SEC |
| May 29, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 130,385 | $106M | 0.1% | No plan | SEC |
| May 28, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 2,052 | $1.7M | 0.0% | No plan | SEC |
| May 24, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 92,563 | $74.9M | 0.1% | No plan | SEC |
| May 23, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 50,767 | $41.1M | 0.1% | No plan | SEC |
| May 22, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 12,974 | $10.4M | 0.0% | No plan | SEC |
| May 21, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 186,259 | $150M | 0.2% | No plan | SEC |
| Mar 11, 2024 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 750 | $565k | 8.7% | Routine | SEC |
| Mar 11, 2024 | Zakrowski Donald A | Officer | Form 144 notice | 750 | $565k | Notice | SEC | |
| Feb 16, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 169,684 | $133M | 0.2% | No plan | SEC |
| Feb 15, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 50,316 | $38.3M | 0.1% | No plan | SEC |
| Feb 15, 2024 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 220,000 | $167M | Notice | SEC | |
| Feb 9, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 206,257 | $153M | 0.2% | Unusual | SEC |
| Feb 8, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 8,743 | $6.5M | 0.0% | No plan | SEC |
| Feb 8, 2024 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 215,000 | $156M | Notice | SEC | |
| Jan 31, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 78,573 | $50.9M | 0.1% | No plan | SEC |
| Jan 30, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 76,215 | $49.2M | 0.1% | No plan | SEC |
| Jan 29, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 54,032 | $34.9M | 0.1% | No plan | SEC |
| Jan 16, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,180 | $762k | 0.0% | No plan | SEC |
| Jan 16, 2024 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 210,000 | $135M | Notice | SEC | |
| Jan 11, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 12,344 | $7.8M | 0.0% | No plan | SEC |
| Jan 10, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 163,730 | $103M | 0.2% | No plan | SEC |
| Jan 9, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 34,538 | $21.8M | 0.0% | No plan | SEC |
| Jan 4, 2024 | Lilly Endowment INC | 10% owner | Form 4 sale | 14,388 | $9.1M | 0.0% | No plan | SEC |
| Jan 4, 2024 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 225,000 | $139M | Notice | SEC | |
| Nov 6, 2023 | Zakrowski Donald A | Officer | Form 144 notice | 670 | $383k | Notice | SEC | |
| Nov 6, 2023 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 670 | $383k | 12.5% | Routine | SEC |
| Oct 11, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 215,000 | $130M | 0.2% | Unusual | SEC |
| Oct 11, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 215,000 | $125M | Notice | SEC | |
| Sep 12, 2023 | Weems Alonzo | EVP, ERM & CECO | Form 4 sale | 1,148 | $678k | 12.9% | Routine | SEC |
| Sep 12, 2023 | Weems Alonzo | Officer | Form 144 notice | 1,148 | $678k | Notice | SEC | |
| Sep 7, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $120M | 0.2% | Unusual | SEC |
| Sep 7, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 210,000 | $118M | Notice | SEC | |
| Aug 31, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 46,541 | $25.8M | 0.0% | No plan | SEC |
| Aug 30, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 6,181 | $3.4M | 0.0% | No plan | SEC |
| Aug 29, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 28,747 | $15.9M | 0.0% | No plan | SEC |
| Aug 28, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 37,660 | $20.6B | 0.0% | No plan | SEC |
| Aug 25, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 63,572 | $35.2M | 0.1% | No plan | SEC |
| Aug 24, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 20,992 | $11.6M | 0.0% | No plan | SEC |
| Aug 23, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,307 | $726k | 0.0% | No plan | SEC |
| Aug 23, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 205,000 | $114M | Notice | SEC | |
| Aug 21, 2023 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 600 | $328k | 10.0% | Routine | SEC |
| Aug 21, 2023 | Zakrowski Donald A | Officer | Form 144 notice | 600 | $328k | Notice | SEC | |
| Aug 15, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 50,222 | $27.3M | 0.0% | No plan | SEC |
| Aug 14, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 164,778 | $88.8M | 0.2% | No plan | SEC |
| Aug 14, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 215,000 | $114M | Notice | SEC | |
| Aug 11, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 83,039 | $43.9M | 0.1% | No plan | SEC |
| Aug 10, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,000 | $1.6M | 0.0% | No plan | SEC |
| Aug 9, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 123,961 | $65.6M | 0.1% | No plan | SEC |
| Aug 9, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 210,000 | $110M | Notice | SEC | |
| Aug 8, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 204,409 | $107M | 0.2% | No plan | SEC |
| Jul 21, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 591 | $276k | 0.0% | No plan | SEC |
| Jul 21, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 205,000 | $95.1M | Notice | SEC | |
| Jun 30, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 164,125 | $76.7M | 0.2% | No plan | SEC |
| Jun 29, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 44,115 | $20.5M | 0.0% | No plan | SEC |
| Jun 28, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 11,760 | $5.5M | 0.0% | No plan | SEC |
| Jun 28, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 220,000 | $102M | Notice | SEC | |
| Jun 22, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 107,022 | $49.2M | 0.1% | No plan | SEC |
| Jun 21, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 31,454 | $14.3M | 0.0% | No plan | SEC |
| Jun 20, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 34,156 | $15.5M | 0.0% | No plan | SEC |
| Jun 16, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 25,015 | $11.4M | 0.0% | No plan | SEC |
| Jun 15, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 27,353 | $12.4M | 0.0% | No plan | SEC |
| Jun 15, 2023 | Norton Johna | EVP, Global Quality | Form 4 sale | 3,294 | $1.5M | 9.9% | Routine | SEC |
| Jun 15, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 225,000 | $101M | Notice | SEC | |
| Jun 14, 2023 | Norton Johna | Officer | Form 144 notice | 3,294 | $1.5M | Notice | SEC | |
| Jun 1, 2023 | Jonsson Patrik | EVP&Pres, LLY Imm, LLY USA&CCO | Form 4 sale | 6,000 | $2.6M | 14.0% | Routine | SEC |
| Jun 1, 2023 | Jonsson Patrik | Officer | Form 144 notice | 6,000 | $2.6M | Notice | SEC | |
| May 19, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 194,354 | $86M | 0.2% | No plan | SEC |
| May 15, 2023 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 600 | $261k | 9.1% | Routine | SEC |
| May 15, 2023 | Zakrowski Donald A | Officer | Form 144 notice | 600 | $261k | Notice | SEC | |
| May 12, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 20,646 | $9.1M | 0.0% | No plan | SEC |
| May 12, 2023 | Lilly Endowment INC | 10% Shareholder | Form 144 notice | 215,000 | $93.6M | Notice | SEC | |
| May 3, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 178,302 | $76M | 0.2% | No plan | SEC |
| May 2, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 41,698 | $17.1M | 0.0% | No plan | SEC |
| May 2, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 220,000 | $89.3M | Notice | SEC | |
| Apr 28, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 225,000 | $89.7M | 0.2% | No plan | SEC |
| Apr 28, 2023 | Lilly Endowment INC | 10% Stockholder | Form 144 notice | 225,000 | $87.8M | Notice | SEC | |
| Apr 6, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 130,297 | $47.9M | 0.1% | No plan | SEC |
| Apr 5, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 69,703 | $25.3M | 0.1% | No plan | SEC |
| Apr 3, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $73.6M | 0.2% | No plan | SEC |
| Mar 31, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $70.1M | 0.2% | No plan | SEC |
| Mar 24, 2023 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $67.2M | 0.2% | No plan | SEC |
| Mar 10, 2023 | Weems Alonzo | EVP, ERM & CECO | Form 4 sale | 1,000 | $319k | 10.1% | Plan not stated | SEC |
| Feb 27, 2023 | Zakrowski Donald A | SVP, Finance, & CAO | Form 4 sale | 600 | $193k | 8.4% | Plan not stated | SEC |
| Feb 13, 2023 | White Anne E. | EVP & Pres, Lilly Neuroscience | Form 4 sale | 5,000 | $1.7M | 7.9% | Plan not stated | SEC |
| Dec 2, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 49,089 | $18.3M | 0.0% | Plan not stated | SEC |
| Dec 1, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 160,911 | $59.8M | 0.2% | Plan not stated | SEC |
| Nov 7, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 63,585 | $23.1M | 0.1% | Plan not stated | SEC |
| Nov 4, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,336 | $486k | 0.0% | Plan not stated | SEC |
| Nov 3, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 133,948 | $48.5M | 0.1% | Plan not stated | SEC |
| Nov 2, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 6,131 | $2.2M | 0.0% | Plan not stated | SEC |
| Oct 21, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 161,936 | $54.8M | 0.2% | Plan not stated | SEC |
| Oct 19, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,547 | $1.2M | 0.0% | Plan not stated | SEC |
| Oct 18, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 12,042 | $4M | 0.0% | Plan not stated | SEC |
| Oct 17, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 79,624 | $26.7M | 0.1% | Plan not stated | SEC |
| Oct 14, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,187 | $1.1M | 0.0% | Plan not stated | SEC |
| Oct 12, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 400 | $133k | 0.0% | Plan not stated | SEC |
| Oct 10, 2022 | Weems Alonzo | EVP, ERM & CECO | Form 4 sale | 656 | $214k | 8.6% | Plan not stated | SEC |
| Oct 6, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 149,264 | $49.9M | 0.1% | Plan not stated | SEC |
| Sep 28, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 101,631 | $34.1M | 0.1% | Plan not stated | SEC |
| Sep 1, 2022 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 1,000 | $301k | 15.9% | Plan not stated | SEC |
| Aug 10, 2022 | Weems Alonzo | SVP, ERM & CECO | Form 4 sale | 656 | $200k | 7.5% | Plan not stated | SEC |
| Jul 28, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 89,458 | $29.8M | 0.1% | Plan not stated | SEC |
| Jul 26, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,601 | $532k | 0.0% | Plan not stated | SEC |
| Jul 15, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 17,310 | $5.8M | 0.0% | Plan not stated | SEC |
| Jul 6, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 177,243 | $58.5M | 0.2% | Plan not stated | SEC |
| Jun 28, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 900 | $296k | 0.0% | Plan not stated | SEC |
| Jun 27, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 41,857 | $13.8M | 0.0% | Plan not stated | SEC |
| Jun 24, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 215,000 | $69.7M | 0.2% | Plan not stated | SEC |
| Jun 23, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $63.8M | 0.2% | Plan not stated | SEC |
| Jun 22, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $64.4M | 0.2% | Plan not stated | SEC |
| Jun 1, 2022 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 1,000 | $313k | 13.7% | Plan not stated | SEC |
| May 27, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $63.8M | 0.2% | Plan not stated | SEC |
| May 26, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 178,390 | $55.5M | 0.2% | Plan not stated | SEC |
| May 25, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 41,610 | $12.9M | 0.0% | Plan not stated | SEC |
| May 24, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 100,000 | $30.6M | 0.1% | Plan not stated | SEC |
| May 23, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 118,856 | $36M | 0.1% | Plan not stated | SEC |
| May 18, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 700 | $211k | 0.0% | Plan not stated | SEC |
| May 17, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 19,683 | $5.9M | 0.0% | Plan not stated | SEC |
| May 16, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 80,761 | $24.4M | 0.1% | Plan not stated | SEC |
| Apr 8, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 139,045 | $43.2M | 0.1% | Plan not stated | SEC |
| Apr 7, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 70,955 | $22M | 0.1% | Plan not stated | SEC |
| Apr 6, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 51,851 | $15.6M | 0.0% | Plan not stated | SEC |
| Apr 5, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 113,756 | $33.4M | 0.1% | Plan not stated | SEC |
| Apr 4, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 39,393 | $11.5M | 0.0% | Plan not stated | SEC |
| Apr 1, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 165,376 | $48.4M | 0.2% | Plan not stated | SEC |
| Mar 30, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 2,500 | $730k | 0.0% | Plan not stated | SEC |
| Mar 29, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 4,341 | $1.3M | 0.0% | Plan not stated | SEC |
| Mar 28, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 7,538 | $2.2M | 0.0% | Plan not stated | SEC |
| Mar 21, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 35,245 | $10.3M | 0.0% | Plan not stated | SEC |
| Mar 18, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $60.5M | 0.2% | Plan not stated | SEC |
| Mar 17, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $62.4M | 0.2% | Plan not stated | SEC |
| Mar 17, 2022 | Jonsson Patrik | SVP&Pres, LLY Imm, LLY USA&CCO | Form 4 sale | 673 | $187k | 2.1% | Plan not stated | SEC |
| Mar 15, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,075 | $60.5M | 0.2% | Plan not stated | SEC |
| Mar 14, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 173,085 | $46.6M | 0.2% | Plan not stated | SEC |
| Mar 11, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 21,840 | $5.9M | 0.0% | Plan not stated | SEC |
| Mar 10, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 184,982 | $49.3M | 0.2% | Plan not stated | SEC |
| Mar 9, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 20,018 | $5.3M | 0.0% | Plan not stated | SEC |
| Mar 4, 2022 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $55.1M | 0.2% | Plan not stated | SEC |
| Mar 1, 2022 | Jonsson Patrik | SVP&Pres, LLY Imm, LLY USA&CCO | Form 4 sale | 675 | $167k | 2.1% | Plan not stated | SEC |
| Feb 25, 2022 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 1,660 | $405k | 18.6% | Plan not stated | SEC |
| Feb 16, 2022 | Yuffa Ilya | SVP & President, LLY Int'l | Form 4 sale | 2,000 | $480k | 14.7% | Plan not stated | SEC |
| Dec 30, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,614 | $1M | 0.0% | Plan not stated | SEC |
| Dec 27, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,570 | $998k | 0.0% | Plan not stated | SEC |
| Dec 16, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 177,616 | $49.8M | 0.2% | Plan not stated | SEC |
| Dec 15, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $55.7M | 0.2% | Plan not stated | SEC |
| Nov 4, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 195,000 | $52.4M | 0.2% | Plan not stated | SEC |
| Oct 28, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 178,631 | $45.2M | 0.2% | Plan not stated | SEC |
| Oct 27, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 21,369 | $5.4M | 0.0% | Plan not stated | SEC |
| Aug 18, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 15,430 | $4.2M | 0.0% | Plan not stated | SEC |
| Aug 17, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,060 | $839k | 0.0% | Plan not stated | SEC |
| Aug 9, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 104,711 | $28M | 0.1% | Plan not stated | SEC |
| Aug 6, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 7,597 | $2M | 0.0% | Plan not stated | SEC |
| Aug 5, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 132,692 | $35.1M | 0.1% | Plan not stated | SEC |
| Aug 4, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 13,458 | $3.6M | 0.0% | Plan not stated | SEC |
| Aug 3, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 236,542 | $60.6M | 0.2% | Plan not stated | SEC |
| Jul 21, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 86,111 | $20.4M | 0.1% | Plan not stated | SEC |
| Jul 20, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 15,610 | $3.7M | 0.0% | Plan not stated | SEC |
| Jul 14, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 10,780 | $2.6M | 0.0% | Plan not stated | SEC |
| Jul 12, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,238 | $768k | 0.0% | Plan not stated | SEC |
| Jul 9, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 109,261 | $25.9M | 0.1% | Plan not stated | SEC |
| Jul 6, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $49.4M | 0.2% | Plan not stated | SEC |
| Jul 2, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 202,102 | $47.1M | 0.2% | Plan not stated | SEC |
| Jun 24, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 12,898 | $3.1M | 0.0% | Plan not stated | SEC |
| Jun 10, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 240,000 | $56.1M | 0.2% | Plan not stated | SEC |
| Jun 9, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $49.5M | 0.2% | Plan not stated | SEC |
| Jun 7, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 230,000 | $51.7M | 0.2% | Plan not stated | SEC |
| May 24, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 7,329 | $1.5M | 0.0% | Plan not stated | SEC |
| May 21, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 92,740 | $18.6M | 0.1% | Plan not stated | SEC |
| May 20, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 99,931 | $20M | 0.1% | Plan not stated | SEC |
| Apr 28, 2021 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 3,000 | $544k | 33.4% | Unusual | SEC |
| Mar 9, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 59,959 | $12.6M | 0.1% | Plan not stated | SEC |
| Mar 8, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 125,284 | $26.3M | 0.1% | Plan not stated | SEC |
| Jan 15, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 215,000 | $41M | 0.2% | Plan not stated | SEC |
| Jan 13, 2021 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $39.1M | 0.2% | Plan not stated | SEC |
| Jan 11, 2021 | Name not stated | 10% owner | Form 4 sale | 220,000 | $40.8M | 0.2% | Plan not stated | SEC |
| Sep 8, 2020 | Barnes Melissa S | Chief Eth/Cmpl Ofcr & SVP, ERM | Form 4 sale | 5,000 | $755k | 17.5% | Plan not stated | SEC |
| Aug 17, 2020 | Fry Stephen F | SVP, HR & Diversity | Form 4 sale | 7,204 | $1.1M | 6.7% | Plan not stated | SEC |
| Jul 9, 2020 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 11,000 | $1.9M | 37.1% | Unusual | SEC |
| Jul 9, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 12,961 | $2.2M | 0.0% | Plan not stated | SEC |
| Jul 7, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $35.1M | 0.2% | Plan not stated | SEC |
| Jul 6, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $34.2M | 0.2% | Plan not stated | SEC |
| Jun 30, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 166,832 | $27.2M | 0.1% | Plan not stated | SEC |
| Jun 29, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 11,431 | $1.9M | 0.0% | Plan not stated | SEC |
| Jun 26, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 31,737 | $5.2M | 0.0% | Plan not stated | SEC |
| Jun 26, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 31,737 | $5.2M | 0.0% | Plan not stated | SEC |
| Jun 18, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 53,770 | $8.7M | 0.0% | Plan not stated | SEC |
| Jun 17, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 161,230 | $26M | 0.1% | Plan not stated | SEC |
| Jun 16, 2020 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 17,000 | $2.8M | 36.4% | Unusual | SEC |
| Jun 16, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 212,337 | $34.6M | 0.2% | Plan not stated | SEC |
| Jun 5, 2020 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 10,000 | $1.5M | 17.7% | Plan not stated | SEC |
| Apr 27, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 12,663 | $2.1M | 0.0% | Plan not stated | SEC |
| Apr 24, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $35.7M | 0.2% | Plan not stated | SEC |
| Apr 23, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 230,000 | $36.8M | 0.2% | Plan not stated | SEC |
| Apr 14, 2020 | Shah Aarti S. | SVP & CIO | Form 4 sale | 2,000 | $300k | 9.5% | Plan not stated | SEC |
| Apr 9, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 230,000 | $33.4M | 0.2% | Plan not stated | SEC |
| Apr 7, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 172,315 | $24.7M | 0.2% | Plan not stated | SEC |
| Apr 6, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 15,962 | $2.3M | 0.0% | Plan not stated | SEC |
| Apr 3, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 26,723 | $3.8M | 0.0% | Plan not stated | SEC |
| Apr 2, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 166,038 | $23.4M | 0.1% | Plan not stated | SEC |
| Mar 31, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 38,962 | $5.5M | 0.0% | Plan not stated | SEC |
| Mar 30, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $29.2M | 0.2% | Plan not stated | SEC |
| Mar 30, 2020 | Fry Stephen F | SVP, HR & Diversity | Form 4 sale | 14,657 | $2M | 12.0% | Plan not stated | SEC |
| Mar 16, 2020 | Norton Johna | Senior VP, Global Quality | Form 4 sale | 4,727 | $619k | 21.1% | Plan not stated | SEC |
| Mar 4, 2020 | O'Neill Myles | SVP & Pres., Mfg. Operations | Form 4 sale | 25,000 | $3.5M | 74.7% | Unusual | SEC |
| Mar 2, 2020 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 3,700 | $474k | 43.8% | Unusual | SEC |
| Feb 5, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $29.3M | 0.2% | Plan not stated | SEC |
| Jan 13, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $28.5M | 0.2% | Plan not stated | SEC |
| Jan 10, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $29M | 0.2% | Plan not stated | SEC |
| Jan 9, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $29.9M | 0.2% | Plan not stated | SEC |
| Jan 8, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 172,650 | $23M | 0.2% | Plan not stated | SEC |
| Jan 7, 2020 | Lilly Endowment INC | 10% owner | Form 4 sale | 32,645 | $4.3M | 0.0% | Plan not stated | SEC |
| Dec 20, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 19,705 | $2.6M | 0.0% | Plan not stated | SEC |
| Dec 18, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $28.4M | 0.2% | Plan not stated | SEC |
| Dec 17, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 215,000 | $27M | 0.2% | Plan not stated | SEC |
| Dec 9, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 10,962 | $1.3M | 0.0% | Plan not stated | SEC |
| Dec 6, 2019 | O'Neill Myles | SVP & Pres., Mfg. Operations | Form 4 sale | 25,000 | $3M | 42.8% | Unusual | SEC |
| Dec 6, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 194,038 | $23.3M | 0.2% | Plan not stated | SEC |
| Dec 6, 2019 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 4,500 | $540k | 13.3% | Plan not stated | SEC |
| Dec 4, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $24.9M | 0.2% | Plan not stated | SEC |
| Nov 27, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 48,953 | $5.8M | 0.0% | Plan not stated | SEC |
| Nov 26, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 56,729 | $6.7M | 0.0% | Plan not stated | SEC |
| Nov 25, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 109,318 | $12.9M | 0.1% | Plan not stated | SEC |
| Nov 22, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 251,736 | $29.3M | 0.2% | Plan not stated | SEC |
| Nov 21, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 108,264 | $12.5M | 0.1% | Plan not stated | SEC |
| Nov 19, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $23.6M | 0.2% | Plan not stated | SEC |
| Nov 18, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 10,598 | $1.2M | 0.0% | Plan not stated | SEC |
| Nov 12, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 7,981 | $910k | 0.0% | Plan not stated | SEC |
| Nov 11, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 100 | $11k | 0.0% | Plan not stated | SEC |
| Nov 7, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 400 | $46k | 0.0% | Plan not stated | SEC |
| Nov 6, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 173,918 | $19.8M | 0.1% | Plan not stated | SEC |
| Nov 4, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 7,003 | $799k | 0.0% | Plan not stated | SEC |
| Oct 31, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 190,000 | $21.7M | 0.2% | Plan not stated | SEC |
| Sep 20, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $24.4M | 0.2% | Plan not stated | SEC |
| Sep 20, 2019 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 4,500 | $527k | 11.7% | Plan not stated | SEC |
| Sep 5, 2019 | Fry Stephen F | SVP, HR & Diversity | Form 4 sale | 9,452 | $1.1M | 8.6% | Plan not stated | SEC |
| Sep 3, 2019 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 19,500 | $2.2M | 33.7% | Unusual | SEC |
| Jun 3, 2019 | Harrington Michael J | Senior VP and General Counsel | Form 4 sale | 16,000 | $1.9M | 12.7% | Plan not stated | SEC |
| May 3, 2019 | Shaw Christi | SVP and Pres., Lilly Bio-Meds | Form 4 sale | 7,577 | $888k | 100.0% | Unusual | SEC |
| Apr 12, 2019 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 10,000 | $1.2M | 14.7% | Plan not stated | SEC |
| Apr 12, 2019 | Barnes Melissa S | Chief Eth/Cmpl Ofcr & SVP, ERM | Form 4 sale | 4,735 | $593k | 17.7% | Plan not stated | SEC |
| Apr 5, 2019 | Shah Aarti S. | SVP & CIO | Form 4 sale | 1,800 | $227k | 8.9% | Plan not stated | SEC |
| Mar 26, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $26.9M | 0.2% | Plan not stated | SEC |
| Mar 22, 2019 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 1,000 | $129k | 17.9% | Plan not stated | SEC |
| Mar 12, 2019 | Fry Stephen F | SVP, HR & Diversity | Form 4 sale | 14,847 | $1.8M | 11.9% | Plan not stated | SEC |
| Mar 1, 2019 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 1,000 | $127k | 15.2% | Plan not stated | SEC |
| Mar 1, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $27M | 0.2% | Plan not stated | SEC |
| Feb 28, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $25.3M | 0.2% | Plan not stated | SEC |
| Feb 22, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 195,000 | $24.2M | 0.2% | Plan not stated | SEC |
| Feb 19, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $25.1M | 0.2% | Plan not stated | SEC |
| Feb 15, 2019 | Conterno Enrique A | SVP&Pres, LillyDiab & LillyUSA | Form 4 sale | 25,000 | $3M | 15.8% | Plan not stated | SEC |
| Jan 31, 2019 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 4,000 | $480k | 8.8% | Plan not stated | SEC |
| Jan 17, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 136,577 | $16.2M | 0.1% | Plan not stated | SEC |
| Jan 16, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 1,657 | $195k | 0.0% | Plan not stated | SEC |
| Jan 15, 2019 | Lilly Endowment INC | 10% owner | Form 4 sale | 51,766 | $6.1M | 0.0% | Plan not stated | SEC |
| Dec 10, 2018 | O'Neill Myles | SVP & Pres., Mfg. Operations | Form 4 sale | 25,000 | $2.8M | 32.9% | Unusual | SEC |
| Dec 4, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 15,500 | $1.8M | 0.0% | Plan not stated | SEC |
| Nov 29, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 185,000 | $21.7M | 0.2% | Plan not stated | SEC |
| Nov 28, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 190,000 | $22M | 0.2% | Plan not stated | SEC |
| Nov 19, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 195,000 | $22.5M | 0.2% | Plan not stated | SEC |
| Nov 16, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $22.7M | 0.2% | Plan not stated | SEC |
| Nov 13, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 2,460 | $279k | 0.0% | Plan not stated | SEC |
| Nov 12, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 202,540 | $23M | 0.2% | Plan not stated | SEC |
| Oct 17, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 174,696 | $19.8M | 0.1% | Plan not stated | SEC |
| Oct 9, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 10,672 | $1.2M | 0.0% | Plan not stated | SEC |
| Oct 8, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 14,632 | $1.7M | 0.0% | Plan not stated | SEC |
| Oct 4, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 116,038 | $13.1M | 0.1% | Plan not stated | SEC |
| Oct 4, 2018 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 7,000 | $802k | 13.4% | Plan not stated | SEC |
| Oct 3, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 78,962 | $8.6M | 0.1% | Plan not stated | SEC |
| Sep 28, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 107,553 | $11.5M | 0.1% | Plan not stated | SEC |
| Sep 27, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 92,447 | $9.9M | 0.1% | Plan not stated | SEC |
| Sep 26, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 134,410 | $14.3M | 0.1% | Plan not stated | SEC |
| Sep 25, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 55,590 | $5.9M | 0.0% | Plan not stated | SEC |
| Sep 18, 2018 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 6,000 | $638k | 10.3% | Plan not stated | SEC |
| Sep 7, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 180,000 | $19.2M | 0.2% | Plan not stated | SEC |
| Sep 4, 2018 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 600 | $63k | 14.5% | Plan not stated | SEC |
| Aug 30, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 190,000 | $20M | 0.2% | Plan not stated | SEC |
| Aug 20, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 195,000 | $20.6M | 0.2% | Plan not stated | SEC |
| Aug 16, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $20.9M | 0.2% | Plan not stated | SEC |
| Aug 15, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 151,793 | $15.7M | 0.1% | Plan not stated | SEC |
| Aug 10, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 3,587 | $370k | 0.0% | Plan not stated | SEC |
| Aug 7, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 24,620 | $2.5M | 0.0% | Plan not stated | SEC |
| Aug 6, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 195,000 | $19.9M | 0.2% | Plan not stated | SEC |
| Aug 2, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 190,000 | $18.9M | 0.2% | Plan not stated | SEC |
| Jul 31, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $20.2M | 0.2% | Plan not stated | SEC |
| Jul 25, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 190,000 | $18M | 0.2% | Plan not stated | SEC |
| Jul 24, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 185,000 | $17M | 0.2% | Plan not stated | SEC |
| Jul 6, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 180,000 | $15.7M | 0.1% | Plan not stated | SEC |
| Jul 5, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 170,000 | $14.7M | 0.1% | Plan not stated | SEC |
| Jun 15, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 180,000 | $15.6M | 0.1% | Plan not stated | SEC |
| Jun 14, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 107,698 | $9.3M | 0.1% | Plan not stated | SEC |
| Jun 13, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 11,104 | $958k | 0.0% | Plan not stated | SEC |
| Jun 11, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 51,198 | $4.4M | 0.0% | Plan not stated | SEC |
| Jun 4, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 135,478 | $11.5M | 0.1% | Plan not stated | SEC |
| Jun 1, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 39,522 | $3.4M | 0.0% | Plan not stated | SEC |
| May 31, 2018 | Conterno Enrique A | SVP&Pres, LillyDiab & LillyUSA | Form 4 sale | 25,000 | $2.1M | 16.7% | Plan not stated | SEC |
| May 30, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 180,000 | $15.1M | 0.1% | Plan not stated | SEC |
| May 29, 2018 | Shaw Christi | SVP and Pres., Lilly Bio-Meds | Form 4 sale | 8,426 | $692k | 100.0% | Unusual | SEC |
| May 11, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 140,000 | $11.5M | 0.1% | Plan not stated | SEC |
| May 3, 2018 | Simmons Jeffrey N | SVP&Pres. Elanco Animal Health | Form 4 sale | 9,027 | $709k | 6.2% | Plan not stated | SEC |
| Apr 25, 2018 | Lilly Endowment INC | 10% owner | Form 4 sale | 180,000 | $14.6M | 0.1% | Plan not stated | SEC |
| Apr 16, 2018 | Mahony Susan | SVP & Pres., Lilly Oncology | Form 4 sale | 22,544 | $1.8M | 44.4% | Unusual | SEC |
| Mar 16, 2018 | Smiley Joshua L | SVP and CFO | Form 4 sale | 3,000 | $238k | 13.0% | Plan not stated | SEC |
| Mar 1, 2018 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 860 | $66k | 34.4% | Unusual | SEC |
| Feb 21, 2018 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 876 | $68k | 26.2% | Unusual | SEC |
| Feb 5, 2018 | Zakrowski Donald A | Chief Accounting Officer | Form 4 sale | 900 | $73k | 17.9% | Plan not stated | SEC |
| Feb 5, 2018 | Simmons Jeffrey N | SVP&Pres. Elanco Animal Health | Form 4 sale | 9,625 | $781k | 6.7% | Plan not stated | SEC |
| Dec 13, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 200,000 | $17.6M | 0.2% | Plan not stated | SEC |
| Dec 11, 2017 | Simmons Jeffrey N | SVP&Pres. Elanco Animal Health | Form 4 sale | 12,500 | $1.1M | 9.1% | Plan not stated | SEC |
| Dec 4, 2017 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 3,532 | $304k | 8.1% | Plan not stated | SEC |
| Dec 4, 2017 | Mahony Susan | SVP & Pres., Lilly Oncology | Form 4 sale | 36,585 | $3.2M | 40.0% | Unusual | SEC |
| Nov 10, 2017 | Zulueta Alfonso G | SVP & President, Lilly Int'l | Form 4 sale | 2,003 | $168k | 4.4% | Plan not stated | SEC |
| Oct 4, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 205,000 | $17.8M | 0.2% | Plan not stated | SEC |
| Sep 29, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 195,000 | $16.6M | 0.2% | Plan not stated | SEC |
| Sep 15, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 190,000 | $15.7M | 0.2% | Plan not stated | SEC |
| Aug 31, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 180,000 | $14.6M | 0.1% | Plan not stated | SEC |
| Jul 31, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 220,000 | $18.3M | 0.2% | Plan not stated | SEC |
| Jun 22, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 210,000 | $17.7M | 0.2% | Plan not stated | SEC |
| Jun 20, 2017 | Lilly Endowment INC | 10% owner | Form 4 sale | 215,000 | $17.9M | 0.2% | Plan not stated | SEC |
| Jun 12, 2017 | Barnes Melissa S | Chief Eth/Cmpl Ofcr & SVP, ERM | Form 4 sale | 1,900 | $153k | 11.9% | Plan not stated | SEC |
| Jun 9, 2017 | Harrington Michael J | Senior VP and General Counsel | Form 4 sale | 22,833 | $1.8M | 26.9% | Unusual | SEC |